Sign in

CIK 0001773751 · Large accelerated filer

Hims & Hers Health, Inc.

Sign in to watch
Ticker
HIMS
Exchange
NYSE
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
415-851-0195
Business address
2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
Former names
Oaktree Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,052,782
in 14 filings, $4.1M under 10b5-1 plans

Net −$4,052,782. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Okupe Oluyemi −$1.7M Chief Financial Officer sold 20% of stake
  2. Boughton Soleil −$1.3M Chief Legal Officer sold 13% of stake
  3. Autor Deborah M. −$467K Chief Policy Officer sold 26% of stake
  4. Chi Michael −$398K Chief Operating Officer sold 3% of stake
  5. Elshenawy Mohamed −$226K CTO sold 4% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-11 Boughton Soleil Chief Legal Officer Grant or award · Restricted Stock Unit +188,111 188,111
2026-03-11 Elshenawy Mohamed CTO Grant or award · Restricted Stock Unit +376,222 376,222
2026-03-11 Dudum Andrew Chief Executive Officer Grant or award · Restricted Stock Unit +413,844 413,844
2026-03-11 Okupe Oluyemi Chief Financial Officer Grant or award · Restricted Stock Unit +300,978 300,978
2026-02-27 Boughton Soleil Chief Legal Officer Sale 10b5-1 −4,651 $15.21 $71K 440,972
2026-02-23 Chi Michael Chief Operating Officer Grant or award +365,058 670,219
2026-02-23 Okupe Oluyemi Chief Financial Officer Grant or award +410,690 502,307
2026-02-23 Boughton Soleil Chief Legal Officer Grant or award +273,794 445,623
2026-02-23 Dudum Andrew Chief Executive Officer Grant or award +794,002 1,672,734
2026-02-03 Okupe Oluyemi Chief Financial Officer Option exercise 10b5-1 +5,262 $5.01 $26K 96,879
2026-02-03 Okupe Oluyemi Chief Financial Officer Sale 10b5-1 −5,262 $26.44 $139K 91,617
2026-02-03 Okupe Oluyemi Chief Financial Officer Option exercise · Stock Option (right to buy) 10b5-1 −5,262 144,051
2026-01-20 Okupe Oluyemi Chief Financial Officer Option exercise 10b5-1 +7,317 $5.01 $37K 98,934
2026-01-20 Okupe Oluyemi Chief Financial Officer Option exercise 10b5-1 +1,750 $11.53 $20K 100,684
2026-01-20 Okupe Oluyemi Chief Financial Officer Sale 10b5-1 −9,067 $30.34 $275K 91,617
2026-01-20 Okupe Oluyemi Chief Financial Officer Option exercise · Stock Option (right to buy) 10b5-1 −7,317 149,313
2026-01-20 Okupe Oluyemi Chief Financial Officer Option exercise · Stock Option (right to buy) 10b5-1 −1,750 42,996
2026-01-05 Okupe Oluyemi Chief Financial Officer Option exercise 10b5-1 +2,178 $5.01 $11K 96,879
2026-01-05 Okupe Oluyemi Chief Financial Officer Option exercise 10b5-1 +3,808 $11.53 $44K 100,687
2026-01-05 Okupe Oluyemi Chief Financial Officer Sale 10b5-1 −9,070 $33.79 $306K 91,617

Page 14 of 15 · 296 trades